Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01879189 · ClinicalTrials.gov registry record · NA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,302
- Enrollment target
NCT01879189: Completed NA study, sponsored by University of Pennsylvania.
NCT01879189 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01879189, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,302 participants
- Enrollment target
Study Summary
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System.
Interventions
- BEHAVIORAL Breast Cancer Screening Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,302 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01879189
The ClinicalTrials.gov registry entry for NCT01879189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Screening Decision Aid is the first listed.
NCT01879189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01879189 about?
NCT01879189 is a clinical study titled "PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk". In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot t...
What is the current status of trial NCT01879189?
This trial is currently completed. It is a NA study. The enrollment target is 1,302 participants. The study started on 2013-09. Estimated completion is 2017-11.
What interventions are being tested in trial NCT01879189?
The interventions under investigation include: Breast Cancer Screening Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT01879189?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.